Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 8/20 | 0.51 |
| ▸ | PNP | P00491 | 3/20 | 0.48 |
| ▸ | TK1 | P04183 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | EDNRA | P25101 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | HBB | P68871 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | VCP | P55072 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL986800 | 0.89 | XDH (0.60) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL15005119 | 0.88 | XDH (0.59) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL556881 | 0.86 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL6755679 | 0.86 | XDH (0.41) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL1831279 | 0.84 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL27983442 | 0.82 | CDK1 (0.59) | CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL26102379 | 0.79 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL72147 | 0.78 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL4621403 | 0.77 | XDH (0.50) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL4857246 | 0.77 | XDH (0.46) | XDHPNPTK1BLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5688778-A | VIRICIDES | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1997-11-18 | — | — | US | claimed |
| EP-0968223-B1 | BIOCONJUGATION OF MACROMOLECULES | SIGMA ALDRICH CO LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-2256133-B1 | Bioconjugation of macromolecules | SIGMA ALDRICH CO LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| EP-2319854-B1 | Bioconjugation Of Macromolecules | SIGMA ALDRICH CO LLC (US) | 2016-11-30 | — | — | EP | disclosed |
| EP-2319855-B1 | Bioconjugation of Macromolecules | SIGMA ALDRICH CO LLC (US) | 2016-04-06 | — | — | EP | disclosed |
| EP-2319854-A1 | Bioconjugation Of Macromolecules | Sigma-Aldrich Co. (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2319855-A1 | Bioconjugation of Macromolecules | Sigma-Aldrich Co. (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2256133-A1 | Bioconjugation of macromolecules | Sigma-Aldrich Co. (US) | 2010-12-01 | — | — | EP | disclosed |
| US-20040116685-A1 | Method for solution phase synthesis of oligonucleotides | PROLIGO LLC | 2004-06-17 | — | — | US | disclosed |
| US-6737236-B1 | DERIVATIZING OLIGONUCLEOTIDES AND PROTEINS USING CYCLOADDITION REACTIONS INCLUDING DIELS-ALDER REACTION OR 1,3-DIPOLAR CYCLOADDITION REACTIONS | PROLIGO, LLC | 2004-05-18 | — | — | US | disclosed |
| EP-0979233-A1 | METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES | NeXstar Pharmaceuticals, Inc. (US) | 2000-02-16 | — | — | EP | disclosed |
| EP-0968223-A1 | BIOCONJUGATION OF MACROMOLECULES | Proligo L.L.C. (US) | 2000-01-05 | — | — | EP | disclosed |
| US-6001966-A | REACTING N-TERMINAL PROTECTED AMINO ACID WITH PEPTIDE STARTING MATERIAL FORMING A PEPTIDE PRODUCT, PARTITIONING FROM UNREACTED MATERIAL AND REAGENTS BASED ON PRESENCE OF N-TERMINAL BLOCKING/ANCHORING GROUP | PROLIGO LLC (US) | 1999-12-14 | — | — | US | disclosed |
| US-5874532-A | USING A N-TERMINAL PROTECTED AMINO ACID MONOMER | NEXSTAR PHARMACEUTICALS, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0767657-A4 | NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT | NEXSTAR PHARMACEUTICALS INC (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1998047910-A1 | METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES | PROLIGO LLC (US) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998030575-A1 | BIOCONJUGATION OF MACROMOLECULES | PROLIGO LLC (US) | 1998-07-16 | — | — | WO | disclosed |
| WO-1998030578-A1 | METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES | PROLIGO LLC (US) | 1998-07-16 | — | — | WO | disclosed |
| EP-0767657-A1 | NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT | NeXstar Pharmaceuticals, Inc. (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1995035102-A1 | NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT | NEXSTAR PHARMACEUTICALS, INC. (US) | 1995-12-28 | — | — | WO | disclosed |